Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Incorporated in 1989, Suven Life Sciences provides a wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven discovery research is focused on discovering and developing new chemical entities (NCEs), which are best-in-class central nervous system therapies for the treatment of cognitive disorders, major depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, gastro-intestinal motility disorders.
| Issue Open | October 31, 2022 - November 10, 2022 |
| Security Name | Suven Life Sciences Limited |
| Issue Size (Shares) | 72,691,239 |
| Issue Size (Amount) | ₹399.80 Crores |
| Issue Price | ₹55 per share |
| Face Value | ₹1 per share |
| Listing At | BSE, NSE |
| Terms of Payment | The full amount of Rs. 55 per share has to be paid at the time of Application. |
| Entitlement | 1 Equity Shares for every 2 Equity Shares held on the Record Date |
| Record Date | October 18, 2022 |
| Credit of Rights Entitlements | October 28, 2022 |
| Bid/Offer Opens On | October 31, 2022 |
| Renunciation of Rights Entitlements | November 3, 2022 |
| Bid/Offer Closes On | November 10, 2022 |
| Deemed Date of Allotment | November 18, 2022 |
| Credit Date | November 21, 2022 |
| Listing Date | November 24, 2022 |
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 128.42 | 21.23 | -72.15 |
| 31-Mar-22 | 108.03 | 17.16 | -122 |
| Amount in ₹ Crore | |||
The Company intends to utilize the Net Proceeds from the Issue towards the funding of the following objects:
1. Meeting costs related to pharmaceutical research & development and clinical trial for molecules in the research pipelines.
2. Repayment of an inter-corporate deposit availed by the Company.
3. General corporate purposes.
5 3.8 Rating:  Vote Here ... |
Suven Life Sciences Limited
8-2-334, SDE Serene Chambers,
6th Floor Road No.5, Avenue 7, Banjara Hills,
Hyderabad – 500 034
Phone: 91 40 2354 1142
Email: info@suven.com
Website: http://www.suven.com/
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: suven.rights@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
The Suven Life Sciences Rights Issue 2022 opens on October 31, 2022, and closes on November 10, 2022.
Suven Life Sciences Rights Issue 2022 Schedule
| Last Date for credit of Rights Entitlements | October 28, 2022 |
| Last Date for renunciation of Rights Entitlements | November 3, 2022 |
| Issue Opening Date | October 31, 2022 |
| Issue Closing Date | November 10, 2022 |
| Date of Allotment (on or about) | November 18, 2022 |
| Date of Credit (on or about) | November 21, 2022 |
| Date of Listing (on or about) | November 24, 2022 |
Suven Life Sciences Rights Issue 2022 price is set at ₹55 per share per equity share.
The eligible shareholders are being offered 1 Equity Shares for every 2 Equity Shares held on the Record Date (October 18, 2022).
The record date for the Suven Life Sciences Rights Issue 2022 is October 18, 2022.
The issue size of Suven Life Sciences Rights Issue 2022 is of 72,691,239 equity shares at ₹55 per share aggregating upto ₹399.80 Crores.
The Letter of Offer for Suven Life Sciences Rights Issue 2022 can be download here.
You can apply for Suven Life Sciences Rights Issue 2022 in two ways:
Steps to apply for Suven Life Sciences Rights Issue 2022 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Suven Life Sciences Rights Issue 2022 using Registrar's website (R-WAP)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
